Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent

[Image: see text] Phosphodiesterase 9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of diabetes and Alzheimer’s disease. Here we report a potent PDE9 inhibitor 3r that has an IC(50) of 0.6 nM and >150-fold selectivity over other PDEs. The HepG2 cell-based assay shows...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Yong-xian, Huang, Manna, Cui, Wenjun, Feng, Ling-Jun, Wu, Yinuo, Cai, Yinghong, Li, Zhe, Zhu, Xinhai, Liu, Peiqing, Wan, Yiqian, Ke, Hengming, Luo, Hai-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281101/
https://www.ncbi.nlm.nih.gov/pubmed/25432025
http://dx.doi.org/10.1021/jm500836h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281101/
https://www.ncbi.nlm.nih.gov/pubmed/25432025
http://dx.doi.org/10.1021/jm500836h

Ejemplares similares